BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qi Y, Yao X, Du X. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1. IUBMB Life 2020;72:452-64. [PMID: 31651086 DOI: 10.1002/iub.2171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Xiang H, Luo M, Hou P, Xiao Z, Huang Z, Feng Q, Zhang R, Li Y, Wu L. miR-124-3p combined with miR-506-3p delay hepatic carcinogenesis via modulating sirtuin 1. Biomarkers 2021;26:196-206. [PMID: 33401967 DOI: 10.1080/1354750X.2020.1854856] [Reference Citation Analysis]
2 Shen Q, Xia Y, Yang L, Wang B, Peng J, Tang M. Midazolam Suppresses Hepatocellular Carcinoma Cell Metastasis and Enhances Apoptosis by Elevating miR-217. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/2813521] [Reference Citation Analysis]
3 Oshima Y, Sano M, Kajiwara I, Ichimaru Y, Itaya T, Kuramochi T, Hayashi E, Kim J, Kitajima O, Masugi Y, Masamune A, Ijichi H, Ishii Y, Suzuki T. Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. Br J Anaesth 2022:S0007-0912(21)00873-4. [PMID: 35120712 DOI: 10.1016/j.bja.2021.12.042] [Reference Citation Analysis]
4 Sun T, Chen J, Sun X, Wang G. Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis. Cancer Cell Int 2021;21:401. [PMID: 34321010 DOI: 10.1186/s12935-021-02104-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Jiang ZT, Han Y, Liu XY, Lv LY, Pan JH, Liu CD. Tripterine Restrains the Aggressiveness of Hepatocellular Carcinoma Cell via Regulating miRNA-532-5p/CXCL2 Axis. Onco Targets Ther 2020;13:2973-85. [PMID: 32308429 DOI: 10.2147/OTT.S238074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Howell L, Jenkins RE, Lynch S, Duckworth C, Kevin Park B, Goldring C. Proteomic profiling of murine biliary-derived hepatic organoids and their capacity for drug disposition, bioactivation and detoxification. Arch Toxicol 2021;95:2413-30. [PMID: 34050779 DOI: 10.1007/s00204-021-03075-3] [Reference Citation Analysis]
7 Yang K, Zou Z, Wu Y, Hu G. MiR-195 suppression alleviates apoptosis and oxidative stress in CCl4-induced ALI in mice by targeting Pim-1. Exp Mol Pathol 2020;115:104438. [PMID: 32277959 DOI: 10.1016/j.yexmp.2020.104438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Li Q, Liu S, Yan J, Sun MZ, Greenaway FT. The potential role of miR-124-3p in tumorigenesis and other related diseases. Mol Biol Rep 2021;48:3579-91. [PMID: 33877528 DOI: 10.1007/s11033-021-06347-4] [Reference Citation Analysis]
9 Tabnak P, Masrouri S, Geraylow KR, Zarei M, Esmailpoor ZH. Targeting miRNAs with anesthetics in cancer: Current understanding and future perspectives. Biomed Pharmacother 2021;144:112309. [PMID: 34653761 DOI: 10.1016/j.biopha.2021.112309] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]